Eco Animal Regulatory News (EAH)

2 Dec 2013 07:00

ECO Animal Health Group plc

(AIM: EAH)

2 December 2013

ECO RECEIVES FURTHER MARKETING AUTHORISATION FOR AIVLOSIN® IN RUSSIA

ECO is pleased to report that the Ministry of Agriculture of the Russian Federation has granted ECO a marketing authorisation for Aivlosin® 625 mg/g water soluble granules for drinking water medication for swine and poultry.

This very important authorisation comes a year after the first marketing authorisation in Russia for Aivlosin® 42.5 mg/g Premix for in-feed medication for swine. This new authorisation now allows for the servicing of both the poultry and pork producing industries and is a major expansion of ECO’s potential market.

Russia is the fourth largest poultry meat producer and seventh largest pork producing country. It has seen annual double-digit growth in pork and poultry meat production in the last 5 years driven by both domestic demand and import substitution, with accelerating adoption of large scale, intensive production techniques.

Aivlosin®, ECO’s patented macrolide antibiotic, is used for the medication of economical important respiratory and enteric (gut) diseases in pigs and poultry.

Peter Lawrence, Chairman of ECO, commented “This authorisation in Russia is most encouraging and is a further positive step in the development of Aivlosin® as a truly global, multi-species and versatile brand. It demonstrates ECO’s continued progress to being a major presence in the global market for animal health products.”

Contacts:

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.

Eco Animal Health Group Plc

Copyright Business Wire 2013